Shares of DexCom Inc. DXCM slid 3.59% to $66.11 Monday, on what proved to be an all-around rough trading session for the ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...

Global sensation Nick Jonas has always been open about his health journey, and recently, the singer reflected on being ...

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy ...

Nick Jonas is finally opening up about his rare health condition as he announces his paid partnership with Dexcom.The ...

The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.

Singer-actor Nick Jonas recently took to social media to talk about his battle with diabetes. He revealed how being diagnosed with it at the age of 13 changed his life. Wife Priyanka Chopra took to ...

DexCom recently experienced a 14% price increase over the past week. This uptick coincides with the company's announcement of FDA clearance for the Dexcom G7 Continuous Glucose Monitoring System ...

Nick Jonas has given a surprising update on his diabetes journey.The Jonas Brothers member was diagnosed with type 1 diabetes ...

Medtronic plc’s diabetes unit posted another win with the U.S. FDA approval of the Simplera continuous glucose monitoring sensor for use with the Minimed 780G pump system, helping the company catch up ...

Nick Jonas reflected on his Type 1 diabetes diagnosis at 13, and how it felt like shutting the door on his dreams. He penned an emotional note. Read here.

RBC Capital lowered the firm’s price target on DexCom (DXCM) to $100 from $115 and keeps an Outperform rating on the shares as part of a ...